Back
Aclaris Therapeutics Vs. ArcBest Industry Stock Comparison
Sell
19
ACRS
Aclaris Therapeutics
Last Price:
1.18
Seasonality Move:
-0.39%
Sell
50
ARCB
ArcBest
Last Price:
110.27
Seasonality Move:
8.82%
Sell
19
Aclaris Therapeutics (ACRS)
is a Sell
Is Aclaris Therapeutics a Buy, Sell or Hold?
- The current Aclaris Therapeutics [ACRS] share price is $1.19. The Score for ACRS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
- ACRS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
50
ArcBest (ARCB)
is a Sell
Is ArcBest a Buy, Sell or Hold?
- The current ArcBest [ARCB] share price is $113.22. The Score for ARCB is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- ARCB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ACRS Stock Price Chart
What is Aclaris Therapeutics's stock price today?
-
The Aclaris Therapeutics share price today is $1.19
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACRS is experiencing slight buying pressure.
ARCB Stock Price Chart
ACRS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 45.5 | Sell |
| Chaikin Money Flow: | 101972 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.18 - 1.28) | Sell |
| Bollinger Bands (100): | (1.12 - 1.28) | Sell |
ARCB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -5.76 | Sell |
| Relative Strength Index (14 RSI): | 36.4 | Sell |
| Chaikin Money Flow: | -68512 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (112.18 - 136.44) | Sell |
| Bollinger Bands (100): | (118.84 - 142.84) | Sell |
ACRS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.19 | Buy |
| 20-day SMA: | 1.23 | Sell |
| 50-day SMA: | 1.22 | Sell |
| 200-day SMA: | 3.05 | Sell |
| 8-day EMA: | 1.2 | Sell |
| 20-day EMA: | 1.22 | Sell |
| 50-day EMA: | 1.24 | Sell |
| 200-day EMA: | 3.27 | Sell |
ARCB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 116.23 | Sell |
| 20-day SMA: | 120.24 | Sell |
| 50-day SMA: | 132.08 | Sell |
| 200-day SMA: | 119.32 | Sell |
| 8-day EMA: | 115.83 | Sell |
| 20-day EMA: | 120.82 | Sell |
| 50-day EMA: | 127.75 | Sell |
| 200-day EMA: | 120.45 | Sell |
Aclaris Therapeutics Earnings Growth & ACRS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.32 per share, an increase next quarter of $0.04 per share, an increase this year of $0.86 per share, and an increase next year of $0.23 per share.
ArcBest Earnings Growth & ARCB Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.18 per share, an increase next quarter of $0.15 per share, an increase this year of $0.97 per share, and an increase next year of $2.58 per share.
Aclaris Therapeutics Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ArcBest Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||